Lenshil 10Mg Capsule

About Lenshil 10Mg Capsule

Lenshil 10mg Capsule contains Lenvatinib, a targeted anticancer medication classified as a tyrosine kinase inhibitor (TKI). It is used to treat progressive or advanced thyroid cancer that no longer responds to radioactive iodine therapy and is also prescribed for certain patients with unresectable hepatocellular carcinoma (liver cancer) who are not suitable candidates for surgery. Lenvatinib works by blocking specific proteins that promote cancer cell growth and the formation of new blood vessels that tumors need to survive. Advanced thyroid cancer, including anaplastic thyroid carcinoma, is more commonly diagnosed in older adults and may present with symptoms such as a rapidly enlarging thyroid gland and voice changes due to nerve involvement. Hepatocellular carcinoma often develops in individuals with underlying liver conditions such as cirrhosis or chronic hepatitis B infection. Patients with a known allergy to Lenvatinib or any of the capsules ingredients should not use this medication. Before starting treatment, patients should inform their healthcare provider about all existing medical conditions and medications. It is also important to notify dentists or oral surgeons about the use of Lenshil 10mg Capsule before undergoing any dental or surgical procedures, as the medicine may increase the risk of bleeding and delay wound healing. Regular monitoring during treatment helps ensure optimal safety and effectiveness.